• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组胺与鼻血管系统:H1和H2组胺受体拮抗剂的影响

Histamine and the nasal vasculature: the influence of H1 and H2-histamine receptor antagonism.

作者信息

Wood-Baker R, Lau L, Howarth P H

机构信息

University Medicine, Southampton General Hospital, UK.

出版信息

Clin Otolaryngol Allied Sci. 1996 Aug;21(4):348-52. doi: 10.1111/j.1365-2273.1996.tb01085.x.

DOI:10.1111/j.1365-2273.1996.tb01085.x
PMID:8889304
Abstract

The aim was to determine the effect of H1- and H2-receptor blockade on histamine-induced changes in nasal airways resistance and lavage protein concentrations. Normal subjects were pretreated with oral cetirizine or ranitidine in a double-blind and randomized manner. Measurements of the concentration of total protein and albumin in nasal lavage fluid together with nasal airway resistance were made before and after challenge. Any effect of treatment was assessed by comparing the areas under the time-response curves. In all nine subjects available for analysis histamine caused an immediate increase in all measurements. Ranitidine reduced the maximum increase in nasal airway resistance, but this effect was significant only in combination with certirizine. The increase in lavage total protein and albumin concentrations was almost completely abolished by cetirizine, whereas ranitidine had less effect. We conclude that the histamine H1-receptor has the greatest effect on changes in nasal vascular permeability induced by topical histamine, whereas the H2-receptor has the greatest effect on nasal obstruction.

摘要

目的是确定H1和H2受体阻滞剂对组胺诱导的鼻气道阻力和灌洗蛋白浓度变化的影响。正常受试者以双盲和随机方式口服西替利嗪或雷尼替丁进行预处理。在激发前后测量鼻灌洗液中总蛋白和白蛋白的浓度以及鼻气道阻力。通过比较时间-反应曲线下的面积来评估治疗的任何效果。在所有可用于分析的9名受试者中,组胺导致所有测量值立即增加。雷尼替丁降低了鼻气道阻力的最大增加,但这种效果仅在与西替利嗪联合使用时才显著。西替利嗪几乎完全消除了灌洗总蛋白和白蛋白浓度的增加,而雷尼替丁的作用较小。我们得出结论,组胺H1受体对局部组胺诱导的鼻血管通透性变化影响最大,而H2受体对鼻阻塞影响最大。

相似文献

1
Histamine and the nasal vasculature: the influence of H1 and H2-histamine receptor antagonism.组胺与鼻血管系统:H1和H2组胺受体拮抗剂的影响
Clin Otolaryngol Allied Sci. 1996 Aug;21(4):348-52. doi: 10.1111/j.1365-2273.1996.tb01085.x.
2
Histamine receptors that influence blockage of the normal human nasal airway.影响正常人鼻气道阻塞的组胺受体。
Br J Pharmacol. 2005 Mar;144(6):867-74. doi: 10.1038/sj.bjp.0706118.
3
Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis.
Allergy. 1989 May;44(4):281-7. doi: 10.1111/j.1398-9995.1989.tb01070.x.
4
Effects of the selective H1 and H2 histamine receptor antagonists loratadine and ranitidine on autonomic control of the heart.
Anesthesiology. 2002 Feb;96(2):336-41. doi: 10.1097/00000542-200202000-00018.
5
Inhibition of histamine-induced nasal obstruction by cetirizine in allergic rhinitis.西替利嗪对变应性鼻炎中组胺诱导的鼻阻塞的抑制作用。
Br J Clin Pharmacol. 1992 Apr;33(4):445-8. doi: 10.1111/j.1365-2125.1992.tb04065.x.
6
Combined histamine H1 and H3 receptor blockade produces nasal decongestion in an experimental model of nasal congestion.组胺H1和H3受体联合阻断在鼻充血实验模型中可产生鼻充血减轻的效果。
Am J Rhinol. 1999 Sep-Oct;13(5):391-9. doi: 10.2500/105065899781367483.
7
The effects of combined H1 and H2 histamine antagonists on alterations in nasal airflow resistance induced by topical histamine provocation.H1和H2组胺拮抗剂联合使用对局部组胺激发诱导的鼻气流阻力改变的影响。
J Allergy Clin Immunol. 1986 Nov;78(5 Pt 1):856-60. doi: 10.1016/0091-6749(86)90230-7.
8
Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis.西替利嗪和氯雷他定对变应性鼻炎患者鼻内抗组胺作用的起效时间。
Allergy. 1997 Feb;52(2):205-9. doi: 10.1111/j.1398-9995.1997.tb00976.x.
9
Effect of H1 and H2 antagonists on nasal symptoms and mediator release in atopic patients after nasal allergen challenge during the pollen season.
Acta Otolaryngol. 1996 Jan;116(1):91-6. doi: 10.3109/00016489609137720.
10
Participation of histamine H1 and H2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR mice.组胺H1和H2受体在ICR小鼠被动皮肤过敏反应诱导的搔抓行为中的作用
Eur J Pharmacol. 1999 Feb 19;367(2-3):361-71. doi: 10.1016/s0014-2999(98)00974-1.

引用本文的文献

1
Combination of H1 and H2 Histamine Receptor Antagonists: Current Knowledge and Perspectives of a Classic Treatment Strategy.H1和H2组胺受体拮抗剂的联合应用:经典治疗策略的当前认知与展望
Life (Basel). 2024 Jan 23;14(2):164. doi: 10.3390/life14020164.
2
A systematic review and meta-analysis of loratadine combined with montelukast for the treatment of allergic rhinitis.氯雷他定联合孟鲁司特治疗变应性鼻炎的系统评价和Meta分析
Front Pharmacol. 2023 Oct 17;14:1287320. doi: 10.3389/fphar.2023.1287320. eCollection 2023.
3
Common Allergens and Immune Responses Associated with Allergic Rhinitis in China.
中国与变应性鼻炎相关的常见变应原及免疫反应
J Asthma Allergy. 2023 Aug 17;16:851-861. doi: 10.2147/JAA.S420328. eCollection 2023.
4
Modulation of Allergic Inflammation in the Nasal Mucosa of Allergic Rhinitis Sufferers With Topical Pharmaceutical Agents.局部用药对变应性鼻炎患者鼻黏膜变应性炎症的调节作用
Front Pharmacol. 2019 Mar 29;10:294. doi: 10.3389/fphar.2019.00294. eCollection 2019.
5
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.国际过敏与鼻科学学会共识声明:变应性鼻炎。
Int Forum Allergy Rhinol. 2018 Feb;8(2):108-352. doi: 10.1002/alr.22073.
6
The role of antihistamines in the treatment of vasomotor rhinitis.抗组胺药在血管运动性鼻炎治疗中的作用。
World Allergy Organ J. 2009 Aug 15;2(8):156-61. doi: 10.1097/WOX.0b013e3181b35322.
7
Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptors.新型长效组胺 H(1)和 H(3)受体拮抗剂 GSK1004723 的药理学特性研究。
Br J Pharmacol. 2011 Nov;164(6):1627-41. doi: 10.1111/j.1476-5381.2011.01285.x.
8
Histamine receptors that influence blockage of the normal human nasal airway.影响正常人鼻气道阻塞的组胺受体。
Br J Pharmacol. 2005 Mar;144(6):867-74. doi: 10.1038/sj.bjp.0706118.
9
Second-generation antihistamines: actions and efficacy in the management of allergic disorders.第二代抗组胺药:在过敏性疾病管理中的作用与疗效
Drugs. 2005;65(3):341-84. doi: 10.2165/00003495-200565030-00004.